ZADITEN 1 mg/5 ml, oral solution bottle, 150 ml
Active ingredients: Ketotifen fumarate, KETOTIFÈNE BASE
Commercialized according to BDPMDispensing in France: Prescription only
Oral solutionbottle, 150 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZADITEN 1 mg/5 ml, solution buvable
- Pharmaceutical form
- solution buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre de 150 ml avec fermeture de sécurité enfant avec mesurette(s) graduée(s) polypropylène
- Marketing authorisation holder
- ALFASIGMA (ITALIE)
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1983
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60067562CIP73244895CIP133400932448951Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| KETOTIFÈNE (FUMARATE DE)solution | 0,0276 g · 100 ml | SA |
| KETOTIFÈNE BASEsolution | 0,02 g · 100 ml | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.